About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Remote Hypertension Management for Black Patients | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT06527794

Remote Hypertension Management for Black Patients

This study will compare two approaches for managing hypertension in Black patients with uncontrolled blood pressure (BP). One approach will include home BP telemonitoring supported by a pharmacist and...

Lead sponsor: Wake Forest University Health Sciences•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Yhenneko J. Taylor, PhD

CONTACT

(704) 355-6562 [email protected]

Asha Ganesan

CONTACT

[email protected]

Sponsors

Lead Sponsor

Wake Forest University Health Sciences

Collaborators

Patient-Centered Outcomes Research Institute

This study is a pragmatic effectiveness-implementation hybrid type 2 trial with two study arms. One arm will include home BP telemonitoring supported by a pharmacist and a community health worker providing centralized self-management support. The other arm will include enhanced usual clinic-based care with a home BP monitor and routine care from providers trained on evidence-based guidelines.

Age

21 - 85 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Black or African American race
•Hypertension diagnosis
•aged 21 to 85 years
•Uncontrolled blood pressure as defined by \[a\] most recent SBP ≥140 mmHg and an additional SBP≥140 mmHg within the past 12 months in an outpatient setting (excluding urgent care, emergency department or surgery clinic), or \[b\] most recent SBP\>160mmHg in an outpatient setting (excluding urgent care, emergency department or surgery clinic), or \[c\] referral by PCP for uncontrolled hypertension with at least one documented SBP≥140 mmHg (in clinic or at home) in the past 12 months; and (v) primary care provided at a participating clinic.
•Able to speak English
•Primary care provided at a participating clinic

Exclusion Criteria

•currently pregnant or planning to get pregnant during the study period
•residence in a long-term care facility, hospice or with a terminal illness with less than 1 year life expectancy as determined by the Primary Care Physician or study team. Stable chronic illness such as compensated cirrhosis, chronic obstructive pulmonary disease, congestive heart failure etc. will not be excluded.
•estimated Glomerular Filtration Rate (eGFR) \<30 ml/min or on dialysis. Patients with a functioning kidney transplant will not be excluded.
•inability to provide informed consent or participate in study procedures. For example, conditions that limit ability to participate in phone visits or check BPs in at least one arm.
•currently participating in another BP management program.
•plan to move out of the area within the next 12 months.
•Hispanic ethnicity.

Related studies

RECRUITINGPhase 3

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

NCT05732727 · Chronic Kidney Disease(CKD), Uncontrolled Hypertension

RECRUITINGPhase 2

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

NCT07142356 · Uncontrolled Hypertension

Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity

NCT07031739 · Uncontrolled Hypertension

COMPLETEDPhase 2

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

NCT06336356 · Uncontrolled Hypertension

SCRATCH-HTN Study: Evaluating Autonomic Neuromodulation Using Trans-cutaneous Vagal Stimulation in Hypertensive Patients

NCT05179343 · Uncontrolled Hypertension, High Blood Pressure

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 13, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment864

Start dateDec 2024

Last updatedJun 13, 2025

Condition

Uncontrolled Hypertension

Locations shown

Wake Forest University Health Sciences

Winston-Salem, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 13, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions